Edmond Scientific Providing Advanced Manufacturing and Biofabrication Expertise to Support Veteran Healthcare

Alexandria, Virginia (October 2023) ––The Department of Veterans Affairs, Veterans Health Administration (VHA), Office of Health Innovation and Learning (OHIL) has awarded Edmond Scientific a contract to support developing biofabrication and advanced manufacturing capabilities within VHA through the Office of Advanced Manufacturing (OAM) and VA Ventures. The effort requires an interdisciplinary team of product development professionals experienced with medical devices and FDA certification, additive manufacturing experts for the fabrication of medical devices and biological bone, and clinical research scientists pushing the frontiers of regenerative medicine to include 3D printing capabilities beyond bone to include vessels, tissue and organs. The effort also includes business analysis and health economic professionals to evaluate clinical and economic outcomes and keep research moving in directions that provide both clinical and business benefits.

For novel medical devices, the effort requires an experienced team to support the medical device product lifecycle from ideation to clinical adoption that includes developing device specifications; executing product development activities including laboratory and bench testing; coordinating with VHA regulatory management to ensure product development complies with applicable clinical and quality standards; and compiling, preparing, and reviewing research quality, preclinical and clinical documentation required for pre- and post-market 510(k), IDE, PMA documentation regulatory submissions to US authorities.

For regenerative medicine applications, the effort requires experience leading and managing complex, interdisciplinary project teams of bioengineers, clinicians and scientific researchers in the biofabrication and regenerative medicine fields.

Edmond Scientific specializes in quickly forming highly specialized scientific, engineering, and analytical teams to address some of the most complex issues facing our federal defense and civilian agencies and is proud to work with VHA stakeholders and provide RDT&E services to advance the development of medical devices and therapeutic interventions in support of veterans.